Navigation Links
APT Test-Fetal Hemoglobin

ProductsAPT Test-Fetal Hemoglobin
Company ARUP Laboratories
Item APT Test-Fetal Hemoglobin
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. D-10 Hemoglobin Testing System with D-10™ Rack Loader
2. Hgb Pro Professional Hemoglobin Testing System
3. B-Hemoglobin Test System
4. Micromat II Hemoglobin A1c Instrument
5. HemoPoint H2 Hemoglobin Measurement System
6. HEMOCUE B-Hemoglobin photometer
7. ultra2 A1c and Hemoglobin Variants Analyzer
8. Lyphochek Hemoglobin A2 Control
9. Lyphochek Hemoglobin A1C Linearity Set
10. DiaSTAT Hemoglobin A1C Analyzer
11. VARIANT II TURBO Hemoglobin Testing System
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products:
(Date:9/5/2008)...meds on Web site shouldn,t overreact or stop takin...ws) -- The U.S. Food and Drug Administration has s...ed for potential safety issues, the agency said Fr...rt, it means we have begun analysis to determine w...ther evaluation," Dr. Gerald Dal Pan, director of ...
(Date:9/5/2008)... Fashion Week,s Annual Destination to Feature Vela...rk (PRWEB) September 5, 2008 -- http://www.ameri...erican Laser], the largest provider of laser hair ...n the U.S., announces sponsorship of the STYLE360 ... Sept. 7-10, serves as the alternative Fashion Wee...
(Date:9/4/2008)...8Private Medicare Advantage (MA) plans will be pai...8 compared to what the same enrollee would have co...gram, according to a new report from The Commonwea...ans mandated by the Medicare Improvements for Pati...to take effect beginning in 2010 had been fully i...
(Date:9/4/2008)...ctions they say could help doctors evaluate risks ...- Vaccine safety experts say that almost all kids ...ons with close monitoring and a set of standard pr...of Pediatrics , a team of experts led by the John...ep set of instructions -- an algorithm -- to help ...
Breaking Medicine News(10 mins):Health News:FDA to List Drugs Under Review for Safety Issues 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2
... the first case of bird flu has been reported in a...ay//. The fatal virus was confirmed on Sept.6 and...e National Task Force on Bird Flu Sam Okware. He ...ealth and veterinary officials in various district...
...ped from the findings of a psychiatrist of Univers...ated 3 million Americans. Dr. Gerald Maguire of th...ng the Indevus Pharmaceuticals in the effort to fi...of a drug for stuttering gave hopeful results, acc...
... says that the life expectancy of those who live i...-American woman may live// two decades longer than...ea. "The evidence is really quite clear that most ...to differences in mortality in young and middle-ag...
... to severe memory loss improved their memories whi...udy//. Researchers, who examined 134 men and wome... the United States, found attention and verbal mem... among severely impaired patients who took rivasti...
Other Medicine News:Health News:Drug Improves Memory Loss for Traumatic Brain Injury Patients 2
(Date:9/3/2008)...om chronically infected Hepatitis C,patients stron...ier in 2008, - Study is the first to show a stat...al effect of therapeutic Hepatitis C vaccination, ...to a second generation, vaccine formulated with I... activation, VIENNA, Au...
(Date:9/3/2008)...wswire/ -- Panacea Pharmaceuticals,Inc. today ann...7 covering,antibodies against human aspartyl (aspa...man cancer biomarker and therapeutic target. These...he Massachusetts Institute of,Technology (MIT) and...atent,for development of human cancer diagnostics ...
(Date:9/3/2008)...tes Zingo Launch Progress and Adlea ...onference Call Today at 11:30 am ET, SOUTH SAN FR... Anesiva,Inc. (Nasdaq: ANSV ) announced today th...s on commercial and late-stage product development...aceutical pain management,company. The company als...
(Date:9/3/2008)...wire-FirstCall/ -- A sub-analysis of,the TRITON-TI...asugrel,compared with clopidogrel significantly re...7.4 percent vs. 9.7 percent, p<0.0001), regardless... an artery-opening,procedure known as percutaneous...spontaneously during the longer-term maintenance p...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Rutgers biomaterial debuts in clinical trials of new stent 4049 1Rutgers biomaterial debuts in clinical trials of new stent 4049 2Rutgers biomaterial debuts in clinical trials of new stent 4049 3Scientists find how amber becomes death trap for watery creatures 876 1Scientists find how amber becomes death trap for watery creatures 876 2Scientists find how amber becomes death trap for watery creatures 876 3Vulnerability to Stress Linked to Brain Molecule 4047 1Vulnerability to Stress Linked to Brain Molecule 4047 2Vulnerability to Stress Linked to Brain Molecule 4047 3Researchers studying how singing bats communicate 874 1Researchers studying how singing bats communicate 874 2